BKV CFO granted 30,407 restricted stock units

Tameron David reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Tameron David reported acquisition or exercise transactions in this Form 4 filing.

BKV Corp reported that Chief Financial Officer Tameron David received a grant of 30,407 restricted stock units of common stock under the 2024 Equity and Incentive Compensation Plan. These units vest in three equal annual installments beginning on March 10, 2027, with each unit delivering one share of common stock when vested.

Following this award, David holds 69,225 shares of BKV common stock directly, and an additional 300 shares are held indirectly through his son.

Insider Trade Summary

Grant/Award: 30,407 shares

Grant/Award 3 txns

Insider Tameron David

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,407	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 69,225 shares (Direct); Common Stock — 600 shares (Indirect, By Son)

Footnotes (1)

1. F1. Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BKV (BKV) report for its CFO?

BKV reported that its Chief Financial Officer, Tameron David, received a grant of 30,407 restricted stock units of common stock. The award is part of the company’s 2024 Equity and Incentive Compensation Plan and represents equity-based compensation, not an open-market share purchase.

How many BKV shares does the CFO hold after this Form 4 filing?

After the reported grant, CFO Tameron David directly holds 69,225 shares of BKV common stock. In addition, 300 shares are reported as being held indirectly through his son, reflecting both his personal and related-party holdings disclosed in the filing.

How do the BKV restricted stock units granted to the CFO vest?

The 30,407 restricted stock units granted to the BKV CFO vest in three equal annual installments. Vesting begins on March 10, 2027, with each vested unit delivering one share of common stock, aligning the executive’s compensation with long-term company performance.

What does each restricted stock unit granted by BKV represent?

Each restricted stock unit granted to the BKV CFO represents a contingent right to receive one share of BKV common stock. Shares are only delivered as the units vest over time, incentivizing continued service and alignment with shareholder interests under the 2024 equity plan.

Is the BKV CFO’s equity grant an open-market share purchase or compensation?

The BKV CFO’s 30,407-share award is equity compensation, not an open-market purchase. It was granted at no cash cost under the 2024 Equity and Incentive Compensation Plan, classified as a grant or award transaction rather than a buy or sell in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 02:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tameron David

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		30,407(1)	A	$0	69,225	D
Common Stock								300	I	By Son
Common Stock								300	I	By Son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.